BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8549879)

  • 21. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Helman CA; Novis BH; Bank S; Wormold L; Jacobs P
    S Afr Med J; 1977 Dec; 52(26):1042-4. PubMed ID: 609977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis.
    Braun A; Treede I; Gotthardt D; Tietje A; Zahn A; Ruhwald R; Schoenfeld U; Welsch T; Kienle P; Erben G; Lehmann WD; Fuellekrug J; Stremmel W; Ehehalt R
    Inflamm Bowel Dis; 2009 Nov; 15(11):1705-20. PubMed ID: 19504612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between smoking and colonic involvement in inflammatory bowel disease.
    Bustamante M; Nos P; Hoyos M; Hinojosa J; Molés JR; García-Herola A; Berenguer J
    Rev Esp Enferm Dig; 1998 Dec; 90(12):833-40. PubMed ID: 9973845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.
    Strugala V; Dettmar PW; Pearson JP
    Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating and mucosal concentrations of tumour necrosis factor and inhibitor(s) in chronic inflammatory bowel disease.
    Nielsen OH; Brynskov J; Bendtzen K
    Dan Med Bull; 1993 Apr; 40(2):247-9. PubMed ID: 8495600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis.
    Pullan RD; Thomas GA; Rhodes M; Newcombe RG; Williams GT; Allen A; Rhodes J
    Gut; 1994 Mar; 35(3):353-9. PubMed ID: 8150346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal glucosamine synthetase activity in inflammatory bowel disease.
    Winslet MC; Poxon V; Allan A; Keighley MR
    Dig Dis Sci; 1994 Mar; 39(3):540-4. PubMed ID: 8131690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis?
    Ansari N; Abdulla J; Zayyani N; Brahmi U; Taha S; Satir AA
    J Clin Pathol; 2006 Oct; 59(10):1066-72. PubMed ID: 16565224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships between clinical data and histology of the large bowel in Crohn's disease and ulcerative colitis.
    Schmitz-Moormann P; Himmelmann GW; Brandes JW
    Pathol Annu; 1985; 20 Pt 1():281-301. PubMed ID: 3991239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of intestinal cytokine messenger RNA profile by real-time quantitative polymerase chain reaction in patients with inflammatory bowel disease.
    Sawa Y; Oshitani N; Adachi K; Higuchi K; Matsumoto T; Arakawa T
    Int J Mol Med; 2003 Feb; 11(2):175-9. PubMed ID: 12525873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of histochemical changes in mucus from patients with ulcerative colitis, Crohn's disease, and diverticular disease of the colon.
    Habib NA; Dawson PM; Krausz T; Blount MA; Kersten D; Wood CB
    Dis Colon Rectum; 1986 Jan; 29(1):15-7. PubMed ID: 3940799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycoprotein synthesis and secretion by mucosal biopsies of rabbit colon and human rectum.
    MacDermott RP; Donaldson RM; Trier JS
    J Clin Invest; 1974 Sep; 54(3):545-54. PubMed ID: 4852174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases.
    Tavano F; Palmieri O; di Mola FF; Latiano A; Burbaci FP; Valvano MR; Corritore G; Augello B; Merla G; Annese V; Andriulli A; di Sebastiano P
    Dig Liver Dis; 2013 Dec; 45(12):1003-10. PubMed ID: 23827863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect.
    Parkes GC; Whelan K; Lindsay JO
    J Crohns Colitis; 2014 Aug; 8(8):717-25. PubMed ID: 24636140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormalities of jejunal mucosal enzymes in ulcerative colitis and Crohn's disease.
    Arvanitakis C
    Digestion; 1979; 19(4):259-66. PubMed ID: 478207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
    Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
    Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking habits in patients with inflammatory bowel disease.
    Benoni C; Nilsson A
    Scand J Gastroenterol; 1984 Sep; 19(6):824-30. PubMed ID: 6515319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease.
    Faioni EM; Ferrero S; Fontana G; Gianelli U; Ciulla MM; Vecchi M; Saibeni S; Biguzzi E; Cordani N; Franchi F; Bosari S; Cattaneo M
    Crit Care Med; 2004 May; 32(5 Suppl):S266-70. PubMed ID: 15118529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis.
    Aldhous MC; Drummond HE; Anderson N; Baneshi MR; Smith LA; Arnott ID; Satsangi J
    Am J Gastroenterol; 2007 Mar; 102(3):589-97. PubMed ID: 17338737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.